Growth deceleration in children treated with imatinib for chronic myeloid leukaemia. [electronic resource]
- European journal of cancer (Oxford, England : 1990) Dec 2014
- 3206-11 p. digital
Publication Type: Journal Article
1879-0852
10.1016/j.ejca.2014.10.007 doi
Adolescent Antineoplastic Agents--adverse effects Benzamides--adverse effects Body Height--drug effects Body Mass Index Child Child, Preschool Female Growth Disorders--chemically induced Humans Imatinib Mesylate Infant Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy Male Piperazines--adverse effects Pyrimidines--adverse effects Retrospective Studies